Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy (Q35078258)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy
scientific article

    Statements

    Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy (English)
    0 references
    Regina Vogelbacher
    Andrea Stief
    Christina Grigo
    Christian Hugo
    23 December 2013

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit